Imbio PHA (4.0.0) vs Tyto Stethoscope
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your clinical practice or hospital radiology department requires advanced, automated analysis of CT pulmonary angiogram (CTPA) scans. This tool is ideal for rapidly and accurately measuring cardiac structures to aid in the diagnosis and risk stratification of conditions like pulmonary embolism and hypertension, enhancing the efficiency and precision of image interpretation.
View Imbio PHA (4.0.0) →Choose Tyto Stethoscope if…
Choose Tyto Stethoscope if you aim to provide comprehensive remote medical examinations and expand telehealth capabilities for a wide range of conditions. This device is perfectly suited for virtual visits, allowing healthcare providers to remotely assess heart, lungs, ears, throat, and skin, making it invaluable for family medicine, pediatrics, and improving patient access to care from any location.
View Tyto Stethoscope →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Tyto Stethoscope |
|---|---|---|
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tyto StethoscopeTyto Stethoscope emphasizes a guided examination process with on-device and in-app instructions, making complex medical exams accessible to a broader audience, including patients and general practitioners. Imbio PHA, while integrating into specialist workflows, does not highlight the same level of guided user experience for a diverse user base.
Clinical Value
Imbio PHA (4.0.0)Imbio PHA provides precise, automated measurements from CT pulmonary angiogram (CTPA) scans, directly aiding in the diagnosis and risk stratification of critical and life-threatening conditions like pulmonary embolism and hypertension. While Tyto Stethoscope offers broad remote exam capabilities, Imbio PHA's specific, high-impact diagnostic support for severe conditions from existing imaging provides a distinct clinical advantage within its domain.
Pricing & Value
Tyto StethoscopeTyto Stethoscope offers greater pricing transparency, providing specific costs for its consumer version and a base price for its professional version. In contrast, Imbio PHA's pricing is only available upon contact, which offers less upfront clarity for potential customers.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA explicitly supports multiple deployment options, including Cloud, Enterprise (on-premise), or via partners, which offers greater flexibility for large healthcare systems with diverse infrastructure requirements. Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, but the on-premise option gives Tool A an edge for enterprise integration.
Innovation
Tyto StethoscopeTyto Stethoscope demonstrates broader innovation by integrating a modular physical device with an AI-powered platform and guided exams to enable comprehensive remote physical examinations across multiple specialties. This holistic approach significantly expands the capabilities and accessibility of telehealth, representing a more disruptive innovation in healthcare delivery.
Support & Docs
Tyto StethoscopeTyto Care provides publicly accessible support resources on its website, including FAQs and user manuals, indicating a structured and transparent support system. Information regarding detailed public support documentation for Imbio PHA is not readily available through general web searches, suggesting less transparency in this area.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Tyto Stethoscope |
|---|---|---|
| Name | Imbio PHA (4.0.0) | Tyto Stethoscope |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | AI-powered, all-in-one modular device and platform for remote medical exams, enabling comprehensive virtual visits for heart, lungs, ears, throat, and skin, along with vital sign measurements. |
| Company | Imbio | Tyto Care |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Pulmonology, Radiology | Family Medicine, Internal Medicine, Pediatrics |
| Key Features | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes) | Remote physical exams (heart, lungs, ears, throat, skin, abdomen); Measures heart rate and body temperature; High-quality digital sounds, images, and video capture; Guided examination process with on-device and in-app instructions; Supports live and asynchronous telehealth workflows; AI-powered diagnostics and clinical decision support (e.g., lung sound identification); HIPAA-compliant cloud storage and encrypted data transmission; Mobile application for iOS and Android devices |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Tyto Stethoscope.
Frequently Asked Questions
More Comparisons
More matchups featuring Imbio PHA (4.0.0) or Tyto Stethoscope
Backers
Who funded each tool's parent company.